Abbott competitorsClear all
Otricath's top competitors include Baxter International, Quest Diagnostics, Ra Medical Systems, Bio-Rad, Philips, Danaher, Pfizer, Roche, Amgen, Johnson & Johnson and Novo Nordisk.
| Save Comparison |  Otricath Otricath (also known as Novo Hill Climbing) is a company that manufactures, develops, and distributes medical devices. |  Baxter International Baxter International is a provider of critical care, nutrition, renal, hospital, and surgical products. |  Quest Diagnostics Quest Diagnostics is a company providing diagnostic testing, information, and services. |  Ra Medical Systems Ra Medical Systems is a company that develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. |  Bio-Rad Bio-Rad is a company engaged in the life science research and serves clinical diagnostics markets. |  Philips Philips (also known as Koninklijke Philips and Royal Philips) is a company providing diagnostic imaging, image-guided therapy, patient monitoring, and health informatics, as well as in consumer health and home care products. |  Danaher Danaher is a company that designs, manufactures, and markets professional, medical, industrial, and commercial products and services. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. |  Roche Roche (also known as F. Hoffmann-La Roch) is a biotech company operating through 2 segments: Pharmaceuticals and Diagnostics. |  Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products. |  Johnson & Johnson Johnson & Johnson is a global holding company that engages in the research and development, manufacture and sale of a range of products in the healthcare field. |  Novo Nordisk Novo Nordisk is a healthcare company that designs and manufactures pharmaceutical products. |
Founding Date | Founding Date 2016 | Founding Date 1931 | Founding Date 1967 | Founding Date 2002 | Founding Date 1952 | Founding Date 1891 | Founding Date 1984 | Founding Date 1849 | Founding Date 1896 | Founding Date 1980 | Founding Date 1886 | Founding Date 1923 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | ||||||||||||
Locations | Locations Houston, US HQ | Locations Deerfield, US HQ Old Toongabbie, AU Wien, AT Braine L'alleud, BE São Paulo, BR Mississauga, CA Providencia, CL see more | Locations Secaucus, US HQ Santana De Parnaiba, BR Dublin, IE Ciudad De México, MX Ciudad De México, MX | Locations Carlsbad, US HQ | Locations Hercules, US HQ Villa Ortúzar, AR Gladesville, AU Wien, AT Temse, BE Bandar Seri Begawan, BN Mississauga, CA see more | Locations Eindhoven, NL HQ North Ryde, AU Anderlecht, BE Zaventem, BE São Paulo, BR Sofia, BG Markham, CA see more | Locations Washington, US HQ Shanghai, CN Mumbai, IN New Delhi, IN Sunbury On Thames, GB | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Bentley, AU Melbourne, AU Mulgrave, AU Sydney, AU see more | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Kew, AU North Ryde, AU Wien, AT Machelen, BE see more | Locations New Brunswick, US HQ Buenos Aires, AR Chippendale, AU Wien, AT Minsk, BY Beerse, BE Brussel, BE see more | Locations Bagsværd, DK HQ Tirana, AL Tizi Ouzou, DZ Buenos Aires, AR Baulkham Hills, AU Wien, AT Baku, AZ see more | |
Employees | Employees 5 | Employees 50,000 | Employees 40,000 | Employees 869% increase | Employees 8,1202% decrease | Employees 80,520 | Employees 67,00012% increase | Employees 88,3004% decrease | Employees 97,735 | Employees 23,4009% increase | Employees 132,2002% decrease | Employees 44,3262% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 43.6 b | Valuation ($) 16.9 b | Valuation ($) 13.4 m | Valuation ($) 18.2 b | Valuation ($) 52.9 b | Valuation ($) 184.4 b | Valuation ($) 222.3 b | Valuation ($) N/A | Valuation ($) 146.1 b | Valuation ($) 443.7 b | Valuation ($) 174.8 b |
Twitter followers | Twitter followers 11 | Twitter followers 15 k | Twitter followers 11.6 k | Twitter followers 19.2 k | Twitter followers 43.7 k | Twitter followers 338.5 k | Twitter followers N/A | Twitter followers 25.4 k | Twitter followers 231.7 k | Twitter followers 99.5 k | Twitter followers 231.3 k | Twitter followers 37.9 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 12 | Number of tweets (last 30 days) 67 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 42 | Number of tweets (last 30 days) 408 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 6 | Number of tweets (last 30 days) 63 | Number of tweets (last 30 days) 82 | Number of tweets (last 30 days) 81 | Number of tweets (last 30 days) 35 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 13.5 | Average likes per tweet (last 30 days) 1.5 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 2.8 | Average likes per tweet (last 30 days) 0.2 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 12.2 | Average likes per tweet (last 30 days) 9.3 | Average likes per tweet (last 30 days) 8.7 | Average likes per tweet (last 30 days) 9.9 | Average likes per tweet (last 30 days) 9.7 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 41.79% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 10.78% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 73.02% | Percentage of tweets with engagement (last 30 days) 98.78% | Percentage of tweets with engagement (last 30 days) 43.21% | Percentage of tweets with engagement (last 30 days) 68.57% |
Alexa Website Rank | Alexa Website Rank N/A | Alexa Website Rank 168057 | Alexa Website Rank 8337 | Alexa Website Rank 194051 | Alexa Website Rank 168173 | Alexa Website Rank 9273 | Alexa Website Rank 105270 | Alexa Website Rank 28407 | Alexa Website Rank 45834 | Alexa Website Rank 200877 | Alexa Website Rank 19571 | Alexa Website Rank 192672 |
Employee Rating | Employee Rating N/A | Employee Rating 3.8 | Employee Rating 3.4 | Employee Rating N/A | Employee Rating 3.4 | Employee Rating 3.8 | Employee Rating 4.1 | Employee Rating 4.2 | Employee Rating N/A | Employee Rating 4 | Employee Rating 4.2 | Employee Rating 4.1 |
Financial | ||||||||||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $11.7b (FY, 2020) | Revenue (est.) $9.4b (FY, 2020) | Revenue (est.) $4.4m (FY, 2020) | Revenue (est.) $2.5b (FY, 2020) | Revenue (est.) €19.5b (FY, 2020) | Revenue (est.) $22.3b (FY, 2020) | Revenue (est.) $41.9b (FY, 2020) | Revenue (est.) CHF63.8b (FY, 2019) | Revenue (est.) $25.4b (FY, 2020) | Revenue (est.) $82.1b (FY, 2019) | Revenue (est.) kr122b (FY, 2019) |
Cost of goods | Cost of goods N/A | Cost of goods $7.1b (FY, 2020) | Cost of goods $5.8b (FY, 2020) | Cost of goods $5.5m (FY, 2020) | Cost of goods $1.1b (FY, 2020) | Cost of goods €10.8b (FY, 2020) | Cost of goods $9.8b (FY, 2020) | Cost of goods $8.7b (FY, 2020) | Cost of goods CHF18.4b (FY, 2019) | Cost of goods $6.2b (FY, 2020) | Cost of goods $27.6b (FY, 2019) | Cost of goods kr20.1b (FY, 2019) |
Gross profit | Gross profit N/A | Gross profit $4.6b (FY, 2020) | Gross profit $3.6b (FY, 2020) | Gross profit ($1.1m) (FY, 2020) | Gross profit $1.4b (FY, 2020) | Gross profit €8.8b (FY, 2020) | Gross profit $12.5b (FY, 2020) | Gross profit $33.2b (FY, 2020) | Gross profit CHF45.4b (FY, 2019) | Gross profit $19.3b (FY, 2020) | Gross profit $54.5b (FY, 2019) | Gross profit kr101.9b (FY, 2019) |
Net income | Net income N/A | Net income $1.1b (FY, 2020) | Net income $1.5b (FY, 2020) | Net income ($36m) (FY, 2020) | Net income $3.8b (FY, 2020) | Net income €1.2b (FY, 2020) | Net income $3.6b (FY, 2020) | Net income $9.7b (FY, 2020) | Net income CHF14.1b (FY, 2019) | Net income $7.3b (FY, 2020) | Net income $15.1b (FY, 2019) | Net income kr39b (FY, 2019) |
Operating ⚠ | ||||||||||||
Countries | Countries N/A | Countries N/A | Countries N/A | Countries N/A | Countries N/A | Countries N/A | Countries 60 (FY, 2020) | Countries 125 (FY, 2019) | Countries N/A | Countries 100 (FY, 2019) | Countries 60 (FY, 2018) | Countries N/A |
Facilities | Facilities N/A | Facilities N/A | Facilities N/A | Facilities N/A | Facilities N/A | Facilities N/A | Facilities 239 (FY, 2020) | Facilities N/A | Facilities N/A | Facilities 190 (FY, 2019) | Facilities N/A | Facilities N/A |
Manufacturing Facilities | Manufacturing Facilities N/A | Manufacturing Facilities 52 (FY, 2019) | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities 35 (FY, 2019) | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities 97 (FY, 2019) | Manufacturing Facilities N/A |
Manufacturing Sites | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites 49 (FY, 2019) | Manufacturing Sites 23 (FY, 2019) | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A |
Patents Issued | Patents Issued N/A | Patents Issued N/A | Patents Issued N/A | Patents Issued N/A | Patents Issued 2 k (FY, 2018) | Patents Issued 1 k (FY, 2019) | Patents Issued N/A | Patents Issued N/A | Patents Issued N/A | Patents Issued N/A | Patents Issued N/A | Patents Issued N/A |
Patients | Patients N/A | Patients N/A | Patients N/A | Patients 64 (Q2, 2018) | Patients N/A | Patients N/A | Patients N/A | Patients N/A | Patients 63.2 m (FY, 2019) | Patients N/A | Patients N/A | Patients N/A |
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 26 (FY, 2019) | Phase I Trials Products N/A | Phase I Trials Products 22 (FY, 2019) | Phase I Trials Products N/A | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 37 (FY, 2019) | Phase II Trials Products N/A | Phase II Trials Products 4 (FY, 2019) | Phase II Trials Products N/A | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 23 (FY, 2019) | Phase III Trials Products N/A | Phase III Trials Products 14 (Feb, 2020) | Phase III Trials Products N/A | Phase III Trials Products N/A |
Suppliers | Suppliers N/A | Suppliers N/A | Suppliers N/A | Suppliers N/A | Suppliers N/A | Suppliers 4.9 k (FY, 2019) | Suppliers N/A | Suppliers N/A | Suppliers N/A | Suppliers N/A | Suppliers 3.5 k (Jun, 2018) | Suppliers N/A |
Funding | ||||||||||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 2.8b | Total funding raised $ 175.5m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View company profiles
Baxter International
HQ
Deerfield, US
Employees
50,000
Baxter International is a provider of critical care, nutrition, renal, hospital, and surgical products.
View companyQuest Diagnostics
HQ
Secaucus, US
Employees
40,000
Quest Diagnostics is a company providing diagnostic testing, information, and services.
View companyRa Medical Systems
HQ
Carlsbad, US
Employees
86↑ 9% increase
Ra Medical Systems is a company that develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases.
View companyBio-Rad
HQ
Hercules, US
Employees
8,120↓ 2% decrease
Bio-Rad is a company engaged in the life science research and serves clinical diagnostics markets.
View company